Industrial, Manufacturing & Heavy Industry Market News

Superdisintegrants market worth will be USD 416.5 million by 2021 according to new research report

Superdisintegrants market worth will be USD 416.5 million by 2021 according to new research report

Global and regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

- Advertising -

According to the report “Superdisintegrants Market By Product Type (Natural Superdisintegrants, Synthetic Superdisintegrants (modified Starch, Crospovidone, Modified Cellulose, Ion Exchange Resins And Calcium Silicates), And Others), By Application (Capsules And Tablets), By Therapeutic Area (gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Haematological Diseases, And Inflammatory Diseases), And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, the Global Superdisintegrants Market was worth USD 286.1 million in 2016 and estimated to be growing at a CAGR of 7.8%, to reach USD 416.5 million by 2021. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.

Browse 170 pages of research report on Global Superdisintegrants Market at…ants-market-2862/

Superdisintegrants are one among the many kinds of excipients utilized in pharmaceutical industry for tablet based drug administration. Disintegrants are substances which expand and dissolve when wet causing the tablet to break apart in digestive tract, releasing active ingredients for absorption.

- Advertising -

They make sure that when the tablet is in contact with water, it breaks downs rapidly into smaller fragments making way for dissolution, thus reducing the time required for the drug release.

The growth of Superdisintegrants market is attributed to factors like growing population of geriatric and paediatric patients, growing generic drugs market, and development of new superdisintegrants in pharmaceutical industry. However, the markets growth is hindered by the declining financial support for R&D fields.

Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.

The Global Superdisintegrants market is segmented based on Product type, application and therapeutic area. Based on crop type – Natural and Synthetic Superdisintegrants.

Synthetic Superdisintegrants are further segmented into modified starch, crospovidone, modified cellulose, ion exchange resins and calcium silicates. Based on Application – Tablets and Capsules.

Based on Therapeutic Area – gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.


Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place.

Increasing financial support for development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of North America and Europe in the market. Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and increasing outsourcing of excipient manufacturing to Asian countries like India and China.

The synthetic superdisintegrant market segment held the largest share of the global superdisintegrants market. This is mainly accounted to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets.

Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.

Some of the key players dominating this market include Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.



News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...